STOCK TITAN

Bioventus (BVS) director and 10% owner reports RSU grant and vesting-related share exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Bioventus Inc. director and 10% owner John A. Bartholdson reported equity compensation and vesting-related transactions with no open-market buying or selling. He received a grant of 25,146 restricted stock units, each representing one share of Class A common stock, at no cash cost.

On a prior date, 32,282 restricted stock units vested and were exercised into 32,282 shares of Class A common stock, leaving no units remaining from that award and resulting in 111,902 directly held shares. He also reports indirect ownership of 6,939,357 shares through Juniper investment entities, over which he shares voting and dispositive power and disclaims beneficial ownership beyond his pecuniary interest. The new RSU grant will vest on the earlier of the day immediately preceding the first Annual Meeting of Stockholders after grant or the first anniversary of grant, subject to continued board service.

Positive

  • None.

Negative

  • None.
Insider Bartholdson John A.
Role null
Type Security Shares Price Value
Grant/Award Restricted Stock Units 25,146 $0.00 --
Exercise Restricted Stock Units 32,282 $0.00 --
Exercise Class A Common Stock 32,282 $0.00 --
holding Class A Common Stock -- -- --
Holdings After Transaction: Restricted Stock Units — 25,146 shares (Direct, null); Class A Common Stock — 111,902 shares (Direct, null); Class A Common Stock — 6,939,357 shares (Indirect, See Footnotes)
Footnotes (1)
  1. Consists of (i) 4,624,431 shares of Class A Common Stock held by Juniper Targeted Opportunity Fund, L.P. ("Juniper Fund"), (ii) 2,239,076 shares of Class A Common Stock held by Juniper Targeted Opportunities, L.P. ("Juniper Targeted Opportunities"), and (iii) 75,850 shares of Class A Common Stock held by Juniper Multi-Strategy Fund, L.P. ("Juniper Multi-Strategy" and, together with Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, the "Juniper Entities"). Juniper HF Investors II, LLC ("Juniper HF II"), Juniper Targeted Opportunity Investors, LLC ("Juniper TO") and Juniper HF Investors, LLC ("Juniper HF") are each the general partner of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, respectively. Juniper Investment Company, LLC ("Juniper Investment Company") provides investment advisory and management services and acts as the investment manager of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy. The Reporting Person is a managing member of Juniper Investment Company, Juniper HF II, Juniper TO and Juniper HF and shares voting and dispositive power with respect to the shares held by the Juniper Entities. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. The RSUs vested on June 2, 2026. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
New RSU grant 25,146 units Restricted stock units granted as board compensation
RSUs exercised 32,282 units RSUs vested and converted into Class A common stock
Direct shares after exercise 111,902 shares Class A common stock directly owned following transactions
Indirect Juniper holdings 6,939,357 shares Class A shares held by Juniper entities associated with Bartholdson
Juniper Fund holdings 4,624,431 shares Class A common stock held by Juniper Targeted Opportunity Fund, L.P.
Juniper Targeted Opportunities 2,239,076 shares Class A common stock held by Juniper Targeted Opportunities, L.P.
Juniper Multi-Strategy 75,850 shares Class A common stock held by Juniper Multi-Strategy Fund, L.P.
RSU vest date June 2, 2026 Date on which a reported RSU award vested
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
derivative security financial
"Transaction code M is described as an exercise or conversion of derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
voting and dispositive power financial
"The Reporting Person ... shares voting and dispositive power with respect to the shares held by the Juniper Entities."
pecuniary interest financial
"The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein."
Annual Meeting of Stockholders financial
"The RSUs shall vest and become exercisable on the earlier of the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bartholdson John A.

(Last)(First)(Middle)
4721 EMPEROR BOULEVARD, SUITE 100

(Street)
DURHAM NORTH CAROLINA 27703

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Bioventus Inc. [ BVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/02/2026M32,282A$0111,902D
Class A Common Stock6,939,357ISee Footnotes(1)(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(3)06/02/2026M32,282 (4) (4)Class A Common Stock32,282$00D
Restricted Stock Units(3)06/03/2026A25,146 (5) (5)Class A Common Stock25,146$025,146D
Explanation of Responses:
1. Consists of (i) 4,624,431 shares of Class A Common Stock held by Juniper Targeted Opportunity Fund, L.P. ("Juniper Fund"), (ii) 2,239,076 shares of Class A Common Stock held by Juniper Targeted Opportunities, L.P. ("Juniper Targeted Opportunities"), and (iii) 75,850 shares of Class A Common Stock held by Juniper Multi-Strategy Fund, L.P. ("Juniper Multi-Strategy" and, together with Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, the "Juniper Entities").
2. Juniper HF Investors II, LLC ("Juniper HF II"), Juniper Targeted Opportunity Investors, LLC ("Juniper TO") and Juniper HF Investors, LLC ("Juniper HF") are each the general partner of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy, respectively. Juniper Investment Company, LLC ("Juniper Investment Company") provides investment advisory and management services and acts as the investment manager of Juniper Fund, Juniper Targeted Opportunities and Juniper Multi-Strategy. The Reporting Person is a managing member of Juniper Investment Company, Juniper HF II, Juniper TO and Juniper HF and shares voting and dispositive power with respect to the shares held by the Juniper Entities. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.
3. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
4. The RSUs vested on June 2, 2026.
5. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Remarks:
/s/ Anthony D'Adamio, Attorney-in-Fact06/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did John A. Bartholdson report at Bioventus (BVS)?

John A. Bartholdson reported equity compensation and vesting-related activity, not market trades. He received 25,146 new restricted stock units and exercised 32,282 previously granted units into 32,282 shares of Class A common stock as part of his director compensation.

How many restricted stock units did Bartholdson receive from Bioventus (BVS)?

He received a grant of 25,146 restricted stock units. Each unit represents a contingent right to one share of Class A common stock. This award is part of his director compensation and vests on a board-service-based schedule described in the disclosure.

When do John A. Bartholdson’s new Bioventus (BVS) RSUs vest?

The new restricted stock units vest on the earlier of the day immediately before the first Annual Meeting of Stockholders after grant or the first anniversary of grant. Vesting requires that he continue serving on the Bioventus board through the applicable vesting date.

Did John A. Bartholdson conduct any open-market trades in Bioventus (BVS) shares?

The reported activity reflects RSU grants and the exercise of restricted stock units into common shares, with no open-market purchase or sale codes disclosed. These transactions are compensation and vesting events rather than discretionary buying or selling in the public market.

How many Bioventus (BVS) shares does Bartholdson hold directly after these transactions?

After exercising 32,282 restricted stock units into Class A common stock, he directly holds 111,902 shares. This figure reflects his direct ownership position following the vesting-related exercise, separate from any additional indirect holdings through affiliated investment entities.

What are the Juniper entities mentioned in John A. Bartholdson’s Bioventus (BVS) filing?

The Juniper entities are investment funds that collectively hold 6,939,357 Bioventus Class A shares. They include Juniper Targeted Opportunity Fund, Juniper Targeted Opportunities, and Juniper Multi-Strategy. Bartholdson shares voting and dispositive power and disclaims beneficial ownership beyond his pecuniary interest.